VXRT: Vaxart Inc. Company Short-Term Debt

Symbol and logo of brand Vaxart Inc. (VXRT)

Vaxart, Inc. (VXRT) is striving for pricing power by developing unique oral vaccines that eliminate the need for injections. This daily price action for the company on GURU.Markets, where the indicator stands at 0.00, links this strategy to monetization plans for tablet-based influenza and norovirus treatments. Meanwhile, operations are strictly regulated by FDA standards regarding the disposal of biomaterials.

VXRT (vaxart.com) Company Short-Term Debts history from 07/04/2022 to 07/19/2025

Vaxart Inc. - analytical breakdowns and key metrics (VXRT)

- current quotes and average value forecast:
Price Chart Vaxart Corp|VXRT - Fair Value Consensus
- market capitalization information:
Market Value Vaxart, Inc.|VXRT - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Vaxart|VXRT - Book Capitalization|Market Cap to Net Assets Ratio vaxart.com|VXRT - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Equity Ratio Vaxart, Inc.|VXRT - Long-Term Debt to Equity|Short-Term Debt to Capital Vaxart Corp|VXRT - Company Total Debt Obligations|Debt to Book Capitalization Ratio Vaxart, Inc.|VXRT - Company Long-Term Loans and Borrowings|Company Current Liabilities Vaxart|Quick Liquidity vaxart.com
- net income and valuation multiples indicators:
VXRT - Net Financial Result
Fundamental company analysis:VXRT - vaxart.com
Flagship merchandise of Vaxart Inc.

Since Vaxart, Inc. (VXRT) funds its oral vaccine clinical trials through grants and external infusions, the lack of stable revenue makes liability control critical. By analyzing short-term debt statistics, an investor tracks the aggregate of loans maturing within one year, which allows for an assessment of liquidity risk and determines the extent to which current capital protects Vaxart, Inc. (VXRT) from default during the product development period.

Competing companies

GILD - Company Short-Term Debt|Company Short-Term Loans and Borrowings CDTX (cidara.com)|Novavax Corp (NVAX) - Company Short-Term Debt|Company Current Liabilities CureVac Pharma|VALN (Valneva SE) - Company Short-Term Debts|Company Short-Term Debts vir.bio|Company Current Liabilities SIGA (SIGA Technologies)|EBS (Emergent BioSolutions Inc) - Company Short-Term Loans and Borrowings|Atea Pharmaceuticals Inc - Company Current Liabilities|Invivyd Inc - Company Short-Term Debt|Enanta Pharmaceuticals - Company Short-Term Debts|Short-Term Debt Volume inovio.com INO|HilleVax (HLVX) - Company Short-Term Debt|Kalaris Therapeutics Inc. - Company Short-Term Loans and Borrowings|Company Current Liabilities DYAI|Company Short-Term Debts NanoViricides Corp|Company Short-Term Debt Talphera, Inc. (TLPH)|Short-Term Debt Volume cocrystalpharma.com|Traws Pharma - Company Current Liabilities|Dogwood Therapeutics Inc. - Company Short-Term Debt|Qualigen - Company Short-Term Debts|ALVR - Company Short-Term Debts|VBIV (vbivaccines.com) - Company Current Liabilities|Company Short-Term Indebtedness VIRI